iTeos Therapeutics, Inc. (ITOS)

Last Closing Price: 10.15 (2025-08-28)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

iTeos Therapeutics, Inc. (ITOS) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
--
$-78.73M
Cost of Goods Sold
--
--
$83.79M
$-83.79M
$6.73M
$-77.06M
$-77.06M
$-78.73M
$-78.73M
$-78.73M
$-78.73M
$-83.79M
$-80.99M
43.56M
43.56M
$-1.81
$-1.81
Balance Sheet Financials
$528.99M
$5.17M
$94.09M
$623.08M
$70.27M
--
$59.01M
$129.28M
$493.80M
$493.80M
$493.80M
38.27M
Cash Flow Statement Financials
$-76.21M
$134.65M
$4.53M
$142.43M
$208.14M
$65.71M
$12.52M
--
--
Fundamental Metrics & Ratios
7.53
--
--
--
--
--
--
--
--
--
--
$-76.59M
--
--
--
--
--
--
--
-15.94%
-15.94%
-12.64%
-15.94%
$12.90
$-1.76
$-1.75